Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis

The purpose of the study is to assess whether there is a correlation between imaging and histology with prognosis in patients with soft tissue and bone MC from the archives of the Rizzoli Orthopaedic Institute all the patients with a histological diagnosis of soft tissue or bone malignant myoepithelioma treated from 1998 to 2021

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myoepithelioma Neoplasms Neoplasms by Histologic Type Neoplasms, Complex and Mixed

Age range

2 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Itituto Ortopedico Rizzoli

Bologna, BO, 40136, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male and female patients treated at Rizzoli Orthopaedic Institute between 01 Jan 1998 and 31 Dec 2021
Age ≥ 2 years old
Diagnosis of soft tissue or bone malignant myoepithelioma (MC-SB)
Patients with available clinical and imaging data

Exclusion criteria

At least one inclusion criterion not met

Treatment and study plan

Clinical Data Review

Other

review the medical records, radiological imaging, and histological data of these patients

Primary outcomes

Correlation

Time frame: At baseline (Day 0)

correlation between imaging and histology with prognosis in patients with soft tissue and bone MC.

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Feb 6, 2024
Registry last updated: Apr 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting